Navigation Links
Nano Propellers may Be Tomorrows Drug Deliverers

Researchers at the University of Illinois at Chicago have created a theoretical blueprint for assembling a nanoscale propeller with molecule-sized blades .

Scientists say the propeller opens the possibility of targeting medicines and regularising their flow into and out of cells.

Petr Krl, Assistant Professor of chemistry at UIC, and his laboratory co-workers, used classical molecular dynamics simulations to learn how tiny propellers pump liquids.

They found that at the molecular level the chemistry of the propeller's blades and their sensitivity to water plays a big role in determining whether the propeller pumps efficiently or just spins with little effect.

If the blades have a hydrophobic, or water-repelling nature, they pump a lot of water. But if they are hydrophilic -- water-attracting -- they become clogged with water molecules and pump poorly, the study showed.

"Pumping rates and efficiencies in the hydrophilic and hydrophobic forms can differ by an order of magnitude, which was not expected," said Prof. Kral.


'"/>




Page: 1

Related medicine news :

1. Reflecting On Personal Values Can Lower Stress Responses
2. Decision-Making Enabled By Neurons: Value Assigned To Available Choices.
3. Learning the Value of Prevention and Treatment in Oral Clefting
4. Warm Watermelon Scores Over Cold In Nutritive Value
5. HIV RNA Level Seen As Little Value In Predicting Treatment
6. Gene Tests to Identify Ovarian Cancer Have Little Clinical Value
7. French Psychiatrists to Study Indian Value System
8. Umbilical Cord Blood Banking of Negligible Value: Experts
9. Study Sheds Light on Value of Newer Antipsychotic Drugs for Schizophrenia
10. Americans Get Least Value For Money In Healthcare
11. Questions Over Value of Glucose Monitoring for Non-insulin Using Diabetes Patients
Post Your Comments:
(Date:5/16/2008)...rstCall/ -- Tempo Participacoes,S.A. (Bovespa: TEM...ding,provider of healthcare administration service... services, announces today its results for the fir...formation contained herein,except where otherwise...,accordance with Brazilian Stock Exchange Commissi...
(Date:5/15/2008)...sing in Targeting Cancer Cells, ...ay 15 /PRNewswire-FirstCall/ -- Abbott scientists,...everal investigative,compounds in the company,s on... Clinical Oncology (ASCO) Annual Meeting, schedule... ABT-263, a Bcl-2 family protein,antagonist, and A...
(Date:5/15/2008)...ng cancer treatment for each individual, researche...resented a study suggesting a simple blood test ca...cacy for patients with metastatic breast cancer. ,...to determine if a particular cancer treatment is w...y significant radiographic changes in tumor size o...
(Date:5/15/2008)...tCall/ -- Digital Power,Corporation (Amex: DPW ) ...cial results for the first quarter ended March 31,...000 for the quarter ended,March 31, 2008, an incre...last year. An operating loss of $165,000 for the f...operating profit of $25,000 for the same quarter,l...
Breaking Medicine News(10 mins):Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 2Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 3Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 4Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 5Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 6Health News:Study suggests blood test can help improve treatment outcomes for breast cancer patients 2Health News:Digital Power Reports Financial Results for the First Quarter Ended March 31, 2008 2Health News:Digital Power Reports Financial Results for the First Quarter Ended March 31, 2008 3
...hat early life sun exposure, from birth to 20 year...omas with BRAF gene mutations . Skin cancers oft...se mutations contribute to the cause of melanomas ...evidence comes from scientists at the University o...
...requently diagnosed cancer in men. More than 218,0... year alone, and more than 27,000 will die . June ...rs Day approaching, its a great time think about t...be proactive about cancer prevention. 'Prostate ca...
... have been affected by fever in the last one week ...th mosquito-borne chikungunya fever , according to...ts have now been identified of having mosquito-bor... say none has died," Health Minister P.K. Sreemath...
...h today confirmed the death of a Madison County re...st case in 2007 and it seems to be much earlier t...le died due to the virus. Four Mississippians hav...ile no other state has had a case, according to th...
Other Medicine News:Health News:Exposure to Sun from Early Life can Increase the Risk of Skin Cancer 2Health News:Tips to Maintain a Healthy Prostate 2Health News:First Case of West Nile Virus Death in Madison County 2
(Date:5/15/2008)...May 15 /- Tigris Pharmaceuticals,Inc...esearch and,Development Agreement (CRADA) with the... clinical and preclinical development of AFP-464, ...AFP-464 is converted to,metabolites which bind cov...optosis., This is part of a four-year CRADA encom...
(Date:5/15/2008)...-Service Plan Positions Blue Cross Blue Shield of ...New Report from HealthLeade...re/ -- HealthLeaders-InterStudy, the,leading provi...hat as the,economy continues to stagnate in Michig... best equipped of all of its competitors to weathe...
(Date:5/15/2008)... 21st Annual Meeting of The American Society of ...ting -, IRVINE, Calif., May 15 /PRNewswire-FirstC...DMI ) today announced the presentation of updated ...g mifamurtide (L-MTP-PE) in,patients with lung met...coma, a rare and often fatal bone tumor that typic...
(Date:5/14/2008)...14 /- Biopure Corporation,(...rom its Phase II coronary,revascularization trial ...vention Journal. The paper is entitled "Proof-of-c...therapeutics in elective percutaneous,coronary rev...emodynamic,results." The manuscript was authored b...
Breaking Medicine Technology:Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3Blue Cross Blue Shield Of Michigan Battles Sluggish Economy With Diverse Product Lineup 2IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 2IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 3IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 4IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 5IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 6Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial 2Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial 3Safer Simpler Better 26 Cost Effective Cosmetic Surgery Anesthesia 1450 1Safer Simpler Better 26 Cost Effective Cosmetic Surgery Anesthesia 1450 2Safer Simpler Better 26 Cost Effective Cosmetic Surgery Anesthesia 1450 3Update on Jill Finley Story Coma Survivor 1448 1Update on Jill Finley Story Coma Survivor 1448 2Figure Skater Peggy Fleming Teams with HealthSaver 3A Raise Healthy Children Through Active Parenting 1446 1Figure Skater Peggy Fleming Teams with HealthSaver 3A Raise Healthy Children Through Active Parenting 1446 2Figure Skater Peggy Fleming Teams with HealthSaver 3A Raise Healthy Children Through Active Parenting 1446 3Figure Skater Peggy Fleming Teams with HealthSaver 3A Raise Healthy Children Through Active Parenting 1446 4Figure Skater Peggy Fleming Teams with HealthSaver 3A Raise Healthy Children Through Active Parenting 1446 5Wellcorps International Unveils New Nutritional Supplements 1444 1Wellcorps International Unveils New Nutritional Supplements 1444 2
...-(BUSINESS WIRE)--May 10, 2007 - According to,The ...ercent of,female respondents seeking treatment for...killers such as Vicodin, OxyContin, Percocet,and F...5 percent of,the mothers who reported a dependency...Clare Waismann, registered addiction,specialist fo...
...May 10th, 2007 - Antisense,Pharma today announced,...ults of a Phase I/II-Study in Pancreatic,Carcinoma...h the,TGF-beta2 Inhibitor AP 12009” has been...al Meeting of the American Society of,Clinical Onc...ois,U.S.A, from June 1st - 5th. , In the Phase I/...
Other Medicine Technology:Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate,Dependency Treatment Are Mothers 2Phase I/II-data on Systemic Application of the TGF-beta2-inhibitor,AP 12009 to be Presented 2
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: